I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Various modalities are used to assess glycemic control in patients with type 2 diabetes. The most common method is the use of fasting blood glucose, as it is cheap, reproducible, and widely available.\[[@ref1]\] It is also the most convenient in a busy clinic. Glycated hemoglobin (HBA1c) levels are usually assessed two to three times yearly in most patients. In developing countries, this is not always done, as the test is expensive and not widely available. Postprandial blood glucose is commonly measured two hours after the onset of a meal as this generally approximates the peak value in patients with diabetes, and provides a reasonable assessment of postprandial hyperglycemia.\[[@ref2]\] There is an ongoing interest in specifically measuring and treating, to target postprandial hyperglycemia. This is because recent studies indicate that elevated postprandial plasma glucose levels are an independent and clinically significant risk factor for cardiovascular disease in non-diabetic and diabetic individuals.\[[@ref3]\] Isolated post-challenge hyperglycemia in the presence of normal fasting plasma glucose and HbA1c levels is associated with a two-fold increase in cardiovascular risk.\[[@ref4]\] Acute hyperglycemia experienced after a meal results in endothelial dysfunction and oxidative stress.\[[@ref5]\] Studies have shown an association between postprandial glucose levels and the development of atherosclerosis.\[[@ref6]\] Although postprandial glucose is significantly related to fasting plasma glucose and HbA1c, some studies have shown that quite a significant percentage of patients experience excessive post-meal glycemic surges and elevated postprandial glucose.\[[@ref7]\] Elevated postprandial glucose has been defined by various bodies. The American Diabetes Association (ADA) recommends a cut-off value of 10 mmol / L^2^. The International Diabetes Federation (IDF) recommends a postprandial glucose level of less than 7.8 mmol / L.\[[@ref8]\] The European Association for the study of diabetes (EASD) recommends less than 7.5 mmol / L.\[[@ref9]\] The American Association of Clinical Endocrinologists (AACE) recommends less than 7.8 mmol / L.\[[@ref10]\] This study aims to evaluate the prevalence of isolated postprandial hyperglycemia in our patients and to identify their clinical characteristics.

E[THICAL]{.smallcaps} A[PPROVAL]{.smallcaps} {#sec1-2}
============================================

Ethical approval for the study was obtained from the Ethics Committee of the hospital and only patients who gave informed consent were recruited.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-3}
=================================================

Setting {#sec2-1}
-------

The study was carried out in the weekly diabetes clinic of the University of Port Harcourt Teaching Hospital. This hospital is the main tertiary / referral center for Rivers State, Nigeria, and the neighboring Bayelsa State. The Rivers State has a heterogeneous population, consisting of several local tribes such as Ikwerre, Ijaw, Kalabari, and so on. There are also a lot of people from other parts of Nigeria and expatriates engaged mainly in the oil and gas industry. Rivers state has a population of about 5.1 million people.

Patients {#sec2-2}
--------

Ninety type 2 diabetic patients attending the outpatient clinic for follow-up were assessed. Patients without acute complications were recruited consecutively.

Study design {#sec2-3}
------------

The study is a cross-sectional descriptive study.

Exclusion criteria {#sec2-4}
------------------

Patients with severe hyperglycemia ± ketonuria.Patients who had not been on a stable oral anti-diabetic drug regimen for at least two months.Newly-diagnosed patients at less than six months of diagnosis.

Procedure {#sec2-5}
---------

On each day of the study, the patients were asked to come to the clinic between 8 a.m and 9 a.m, and had been asked to fast from the previous night for eight to ten hours. Each patient had to fill a structured questionnaire, to obtain the demographic data of age, gender, time since diagnosis, and type of diabetic treatment. Clinical assessments of weight and height were made using the standard scales. Body mass index was calculated with the formula weight (kg) / Height^2^ (m). Overweight was defined as BMI of 25 -- 29.9 kg / m^2^, while obesity was defined as BMI ≥ 30 k / m^2^. Blood pressure was then measured with a mercury sphygmomanometer on the right arm, and the average of two readings, taken five minutes apart, was recorded for each participant. Hypertension was said to be present in those with systolic blood pressure ≥ 140 mmHg and / or diastolic blood pressure ≥ 90 mmHg or use of anti-hypertensive medication. A fasting venous sample was then collected for the measurement of fasting plasma glucose. A drop of the blood sample was then extracted using the blood key of the in2it machine for the assessment of glycated hemoglobin. This was then put into the cartridges and the HbA1c was assessed immediately after calibration of the machine, according to the manufacturer\'s instructions. The in2it machine measured Hba1c using the boronate affinity method and it was Diabetes Control and Complications Trial (DCCT) calibrated. The rest of the sample was placed in fluoride oxalate bottles and immediately sent to the laboratory, where it was centrifuged and the plasma separated to measure the plasma glucose, using the glucose oxidase method. Each patient was then served the appropriate doses of their drugs and after 30 minutes each was asked to consume a test meal that had been prepared by the hospital dietitian. The meal was measured to provide 500 kcal of energy and contained 50 g of glucose. The meal was made up of 53% carbohydrate, 17% protein, and 30% lipids. Each patient was asked to finish the meal in fifteen minutes.

Two hours from the onset of the meal another venous blood sample was collected for the measurement of PPG and analyzed in the laboratory in the same manner as the FPG analysis. An FPG of 7.2 mmol / L, PPG 10.0 mmol / L, and HbA1c \< 7% were considered satisfactory according to the ADA guidelines. The patients were considered to have isolated postprandial hyperglycemia if they had FPG \< 7.2 mmol / L and PPG \> 10.0 mmol / L.

Statistical analysis {#sec2-6}
--------------------

This was done with the SPSS version 15 package. The mean ages, duration of diabetes, systolic blood pressure, diastolic blood pressures, and BMI were calculated. The Pearsons correlation coefficient was used to assess the linear correlations between FPG and PPG, PPG and HbA1c, Age and PPG, and duration of diabetes and PPG. A *P* value of \< 0.05 was considered to be significant. Other continuous variables were compared with the student\'s t-test, while categorical variables were assessed with the Chi-square test.

R[ESULTS]{.smallcaps} {#sec1-4}
=====================

The clinical characteristics of the study population are as shown in [Table 1](#T1){ref-type="table"}. Oral drugs were the most frequently prescribed anti-diabetic agents and were used either singly or in combination in 71.1% of the patients. Only six patients (6.7%) were on diet and lifestyle measures alone, while 20 were on insulin treatment, either alone or in combination with metformin. Even as the mean fasting plasma glucose in the study population was 7.5 ± 3.3 mmol / L,- the mean two hour postprandial glucose (PPG) of the study population was 11.0 ± 4.0 mmol / L and the mean HBA1c for the study population was 9.0 ± 2.5%.

###### 

Clinical characteristics of the study population

![](IJEM-16-604-g001)

The proportion of patients with satisfactory glycemic control in the various modalities is as shown in [Table 2](#T2){ref-type="table"}.

###### 

Proportion of patients with satisfactory glycemic control in various parameters

![](IJEM-16-604-g002)

There was a significant correlation between PPG and HbA1c (*P* = 0.000). Isolated postprandial hyperglycemia was seen in 24.4% of the population. The major characteristics of the patients with isolated postprandial hyperglycemia are as listed in [Table 3](#T3){ref-type="table"}. In this sub-set of patients, the highest mean PPG was recorded in patients on oral drugs and the least in those on insulin, although the difference was not statistically significant (*P* = 0.31). Their mean HBA1c was 7.9%.

###### 

Characteristics of patients with isolated postprandial hyperglycemia

![](IJEM-16-604-g003)

There was a significant negative correlation between age and PPG. (r = -- 0.296, *P* = 0.005). There was a positive correlation between postprandial glucose and duration of diabetes after adjusting for fasting plasma glucose, (r = 0.24, *P* = 0.02). There was a negative correlation between body mass index and PPG, but it was not statistically significant. (r = -- 0.197, *P* = 0.066). The difference in the mean postprandial glucose was not statistically significant across the BMI groups, however, those who had a normal BMI tended to have higher postprandial glucose than those who were obese or underweight (11.9 mmol / L vs. 10.5 mmol / L, *P* = 0.103). Comparison of mean PPG among those on oral drugs or diet and those on insulin showed that the difference in their mean PPG was statistically significant. Those on insulin had the highest mean PPG (f = 4.8, *P* = 0.010). When the patients were further subdivided, those on metformin alone had a lower mean PPG than those on a combination of metformin and sulfonylurea and those on sulfonylurea alone. The difference in means was, however, not statistically significant (*P* = 0.18, *P* = 0.15, respectively).

D[ISCUSSION]{.smallcaps} {#sec1-5}
========================

Recent studies have shown that postprandial hyperglycemia is detrimental, as it is an independent risk factor for cardiovascular disease.\[[@ref3]\] Our study set out to estimate the prevalence and correlates of postprandial hyperglycemia in patients with type 2 diabetes and also to identify patients with isolated postprandial hyperglycemia, who are presumed to have optimal glycemic control.

The prevalence of postprandial hyperglycemia (75.6%) was high in the study population. It could be argued that the high prevalence of postprandial hyperglycemia in the patients was a reflection of the high fasting glucose levels in them. This was because there was a significant positive correlation between FPG and PPG.\[[@ref11]\] There was also a positive correlation between postprandial glucose and HbA1c. This significant correlation has been reported in other studies.\[[@ref7][@ref11]\] Hence it can be seen that the three parameters of glycemic control are closely related.

The high prevalence of postprandial hyperglycemia noted in this study was similarly reported in studies by Bonora\[[@ref7]\] and Erlinger,\[[@ref12]\] although patients in these studies had lower fasting plasma glucose levels. Isolated postprandial hyperglycemia was defined in this study as elevated PPG in patients with normal FPG levels. The prevalence of isolated postprandial hyperglycemia was 24.4%. This was similar to the prevalence reported in the study by Bonora,\[[@ref7]\] who reported isolated postprandial hyperglycemia in 38% of the patients.

These patients with isolated postprandial hyperglycemia are at risk of cardiovascular disease as studies have described elevated PPG levels as independent cardiovascular risk factors. Hence, it is important to identify this sub-set of patients who apparently have good metabolic control, but are at risk of cardiovascular disease. The characteristics of these patients are summarized in [Table 2](#T2){ref-type="table"}, to see if there are any simple clinical characteristics that can identify them. It has been noted that these patients were older, had a longer duration of diabetes, and tended to be overweight. This is similar to the findings by Bonora *et al*.\[[@ref7]\] The mean HbA1c of these patients was 7.9%, suggesting that they had a fairly good glycemic control. This suggests that in these patients, the major determinant of their glycated hemoglobin level is their PPG levels, hence, at near-normal HbA1c levels postprandial glucose becomes the key determinant of HbA1c and this is in agreement with other studies.\[[@ref13][@ref14]\] Monnier *et al*. demonstrated that PPG becomes a major contributor to overall glycemic control at an HbA1c level of 8.4%.\[[@ref13]\] It is therefore likely that further reductions in glycated hemoglobin levels in this group of patients will be more easily achieved with drugs that specifically target postprandial glucose.

In this study, PPG was found to be significantly associated with age, duration of diabetes, and fasting plasma glucose. Younger patients had higher postprandial glucose levels and there was a negative correlation between age and postprandial glucose. However, in the overall patient population, the younger patients also had a significantly higher FPG (*P* = 0.000). In contrast, the patients with isolated postprandial hyperglycemia were older; therefore, after excluding those with high fasting glucose, older age appeared to be significantly associated with elevated postprandial glucose.

Postprandial glucose also showed a significant positive correlation with the duration of diabetes and patients with isolated postprandial hyperglycemia had a longer duration of diabetes. This suggested that the longer the duration of diabetes, the more likely it was that a patient would have elevated postprandial glucose, possibly also due to a declining beta cell function. This relationship between PPG and the duration of diabetes was also observed in the study by Bonora.\[[@ref7]\]

In our study, patients who were not obese or overweight had higher PPG levels than obese patients. This, however, did not reach statistical significance. This was in sharp contrast to our finding in patients with isolated postprandial hyperglycemia, who tended to be overweight. Hence, obesity may not be a significant determinant of PPG levels in our patients. Bonora *et al*.\[[@ref7]\] reported that the absence of obesity was significantly associated with elevated PPG.

The highest mean PPG was recorded in patients who were managed with insulin. This was, however, as expected, because they also had the highest mean fasting blood glucose and mean HbA1c than those on other modalities of treatment, hence, they had a poorer glycemic control. Also, the type of insulin known to be beneficial in reducing PPG, that is, rapid-acting insulin, such as aspart or rapid acting / isophane mixture such as Novolog mix or Humalog mix were not being used by the patients in this study.\[[@ref15]\] In a similar study by Singh *et al*. in South Africa,\[[@ref15]\] they evaluated the effects of three types of basal insulin on PPG, and reported that basal insulin was ineffective in controlling postprandial hyperglycemia, and recommended the use of a combination of rapid-acting / newer long-acting analogs such as glargine.

Patients on metformin alone had lower postprandial glucose levels than those on sulfonylureas, although this difference was not statistically significant. This was similar to the findings by Bonora *et al*.,\[[@ref7]\] who noted that treatment with sulfonylureas was associated with higher PPG levels. In that study, however, patients on insulin were excluded.

Limitations {#sec2-7}
-----------

The study was limited by its cross-sectional nature. Blood glucose measurements were done only once. This may not reflect the daily variations normally seen in patients.

Recommendations {#sec2-8}
---------------

There is a need for improved diabetic control overall through patient education and self-monitoring of blood glucose.There is a need for increased awareness and monitoring of postprandial blood glucose in patients.Patients with isolated postprandial hyperglycemia should be identified and treated.In developing countries where glycated hemoglobin may not be routinely tested in patients, monitoring PPG levels in addition to FPG should be advocated and may be an excellent way to prevent complications of diabetes.

C[ONCLUSION]{.smallcaps} {#sec1-6}
========================

In this study elevated postprandial glucose levels were found to occur in patients with normal or near-normal HbA1c levels. In these patients, who were near the HbA1c target, postprandial glucose became the significant contributor for poor glycemic control and drugs specifically targeting postprandial glucose were more likely to help them achieve their target HbA1c levels, hence, reducing the incidence of long-term diabetic complications. Older age, longer duration of diabetes, and the absence of obesity could predict postprandial hyperglycenia and could be used to identify patients, who might need more extensive investigation and monitoring of their PPG levels. The use of FPG and HbA1c alone, for monitoring may be insufficient to prevent long-term complications of diabetes, especially cardiovascular complications.
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